Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion

Reuters

Feb 17

Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion

Labcorp reported revenue of USD 2.00 billion for the fourth quarter (Q4) of 2025 and USD 8.88 billion for the full year (FY) 2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share $(EPS)$ for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602170650PR_NEWS_USPR_____DC89006) on February 17, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2612594294"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612594294\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612594294?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-17 19:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612594294","market":"nz","top_or_hot":-1,"title":"Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Labcorp reported revenue of USD 2.00 billion for the fourth quarter (Q4) of 2025 and USD 8.88 billion for the full year (FY) 2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a> for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602170650PR_NEWS_USPR_____DC89006) on February 17, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-17 19:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Labcorp reported revenue of USD 2.00 billion for the fourth quarter (Q4) of 2025 and USD 8.88 billion for the full year (FY) 2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a> for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602170650PR_NEWS_USPR_____DC89006) on February 17, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDLb5Wf3h:1","article_id":"2612594294","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612594294","pubTimestamp":1771329039,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Labcorp reported revenue of USD 2.00 billion for the fourth quarter  of 2025 and USD 8.88 billion for the full year  2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share  for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LH":"徕博科","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4196":"保健护理服务","BK4550":"红杉资本持仓","BK4588":"碎股"},"translate_title":"Labcorp第四季度调整后每股收益升至4.07美元，增长18%，营收为35.2亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":0.9},"content_text":"Labcorp Q4 adjusted EPS rises to USD 4.07, up 18%, on revenue of USD 3.52 billion\n    \n\n        Labcorp reported revenue of USD 2.00 billion for the fourth quarter (Q4) of 2025 and USD 8.88 billion for the full year (FY) 2025. Net earnings attributable to shareholders reached USD 164.7 million for Q4 2025 and USD 876.5 million for FY 2025. Diluted earnings per share $(EPS)$ for Q4 2025 were USD 1.98, while full-year diluted EPS stood at USD 10.46. Adjusted EPS was USD 4.07 for Q4 2025 and USD 16.44 for FY 2025. Adjusted operating income as a percentage of revenue increased by 1.2 percentage points in Q4 2025, primarily driven by organic growth in Diagnostics and Central Labs. The company also recorded gains and losses related to its investments in technology-focused companies and funds, as well as a gain from the sale of its Beacon Laboratory Benefits Solutions business and a charge related to the settlement of certain U.S. pension plan obligations.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602170650PR_NEWS_USPR_____DC89006) on February 17, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}